Anticonvulsant treatment of asphyxiated newborns under hypothermia with lidocaine: efficacy, safety and dosing
- 8 January 2013
- journal article
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 98 (4) , F341-F345
Abstract
Background Lidocaine is an antiarrythmicum used as an anticonvulsant for neonatal seizures, also during therpeutic hypothermia following (perinatal) asphyxia. Hypothermia may affect the efficacy, safety and dosing of lidocaine in these patients. Objective To study the efficacy and safety of lidocaine in newborns with perinatal asphyxia during moderate hypothermia, and to develop an effective and safe dosing regimen. Methods Hypothermic newborns with perinatal asphyxia and lidocaine for seizure control were included. Efficacy was studied using continuous amplitude-integrated electroencephalography. Safety was assessed using continuous cardiac monitoring. An optimal dosing regimen was developed with simulations using data from a pharmacokinetic model. Plasma samples were collected during hypothermia on consecutive mornings. Results A total of 22 hypothermic and 26 historical normothermic asphyxiated newborns with lidocaine were included. A response of 91% on epileptiform activity on the amplitude-integrated EEG was observed for lidocaine add-on therapy. No relationship between lidocaine or MEGX plasma concentrations and heart frequency could be identified. None of the newborns experienced cardiac arrythmias. Hypothermia reduced lidocaine clearance by 24% compared with normothermia. A novel dosing regimen was developed an initial bolus loading dose of 2 mg/kg, for patients with body weight 2.0–2.5 kg followed by consecutive continuous infusions of 6 mg/kg/h (for 3.5 h), 3 mg/kg/h (for 12 h), 1.5 mg/kg/h (for 12 h), or for patients with bodyweights 2.5–4.5 kg 7 mg/kg/h (for 3.5 h), 3.5 mg/kg/h (for 12 h), 1.75 mg/kg/h (for 12 h), before stopping. Conclusions Lidocaine can be assumed to be an effective antiepileptic drug during hypothermia in asphyxiated neonates.Keywords
This publication has 22 references indexed in Scilit:
- Easy and fast LC–MS/MS determination of lidocaine and MEGX in plasma for therapeutic drug monitoring in neonates with seizuresJournal of Chromatography B, 2012
- Lidocaine (Lignocaine) Dosing Regimen Based upon a Population Pharmacokinetic Model for Preterm and Term Neonates with SeizuresClinical Pharmacokinetics, 2011
- Effects of Hypothermia on Pharmacokinetics and PharmacodynamicsClinical Pharmacokinetics, 2010
- Pharmacology ReviewNeoReviews, 2008
- The TOBY Study. Whole body hypothermia for the treatment of perinatal asphyxial encephalopathy: A randomised controlled trialBMC Pediatrics, 2008
- Development of an optimal lidocaine infusion strategy for neonatal seizuresEuropean Journal of Pediatrics, 2006
- Cardiac arrhythmias in neonates receiving lidocaine as anticonvulsive treatmentEuropean Journal of Pediatrics, 2004
- Effect of hypothermia on cerebral blood flow and metabolism in the pigThe Annals of Thoracic Surgery, 2002
- Rate-dependence of antiarrhythmic and proarrhythmic properties of class I and class III antiarrhythmic drugsBasic Research in Cardiology, 1998
- Anti-arrhythmic effects of lidocaine metabolitesAmerican Heart Journal, 1974